Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Djaldetti, R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Djaldetti, R; Melamed, E; Gadoth, N
      Abnormal skin wrinkling in the less affected side in hemiparkinsonism - a possible test for sympathetic dysfunction in Parkinson's disease

      BIOMEDICINE & PHARMACOTHERAPY
    2. Djaldetti, R; Rosmarin, V; Ziv, I; Melamed, E
      The pharmacokinetic profile of the "first ever" oral dose of levodopa in de novo patients with Parkinson's disease

      CLINICAL NEUROPHARMACOLOGY
    3. Djaldetti, R; Melamed, E
      New therapies for Parkinson's disease

      JOURNAL OF NEUROLOGY
    4. Vila, M; Jackson-Lewis, V; Vukosavic, S; Djaldetti, R; Liberatore, G; Offen, D; Korsmeyer, SJ; Przedborski, S
      Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    5. Przedborski, S; Jackson-Lewis, V; Djaldetti, R; Liberatore, G; Vila, M; Vukosavic, S; Almer, G
      The parkinsonian toxin MPTP: action and mechanism

      RESTORATIVE NEUROLOGY AND NEUROSCIENCE
    6. Rabey, JM; Sagi, I; Huberman, M; Melamed, E; Korczyn, A; Giladi, N; Inzelberg, R; Djaldetti, R; Klein, C; Berecz, G
      Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: A double-blind study as adjunctive therapy to levodopa

      CLINICAL NEUROPHARMACOLOGY
    7. Jackson-Lewis, V; Vila, M; Djaldetti, R; Guegan, C; Liberatore, G; Liu, J; O'Malley, KL; Burke, RE; Przedborski, S
      Developmental cell death in dopaminergic neurons of the substantia nigra of mice

      JOURNAL OF COMPARATIVE NEUROLOGY
    8. Djaldetti, R; Mosberg-Galili, R; Sroka, H; Merims, D; Melamed, E
      Camptocormia (bent spine) in patients with Parkinson's disease - Characterization and possible pathogenesis of an unusual phenomenon

      MOVEMENT DISORDERS
    9. Bessler, H; Djaldetti, R; Salman, H; Bergman, M; Djaldetti, M
      IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson's disease

      BIOMEDICINE & PHARMACOTHERAPY
    10. Salman, H; Bergman, M; Djaldetti, R; Bessler, H; Djaldetti, M
      Decreased phagocytic function in patients with Parkinson's disease

      BIOMEDICINE & PHARMACOTHERAPY
    11. Melamed, E; Zoldan, J; Galili-Mosberg, R; Ziv, I; Djaldetti, R
      Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa

      JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    12. Merims, D; Ziv, I; Djaldetti, R; Melamed, E
      Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease

      LANCET
    13. Ziv, I; Avraham, M; Dabby, R; Zoldan, J; Djaldetti, R; Melamed, E
      Early-occurrence of manual motor blocks in Parkinson's disease: a quantitative assessment

      ACTA NEUROLOGICA SCANDINAVICA
    14. DJALDETTI R; ZIV I; MELAMED E
      EXTREME ANTICIPATION IN YOUNG-ONSET PARKINSONS-DISEASE

      Movement disorders
    15. MELAMED E; OFFEN D; SHIRVAN A; DJALDETTI R; BARZILAI A; ZIV I
      LEVODOPA TOXICITY AND APOPTOSIS

      Annals of neurology
    16. ZIV I; DJALDETTI R; ZOLDAN Y; AVRAHAM M; MELAMED E
      DIAGNOSIS OF NONORGANIC LIMB PARESIS BY A NOVEL OBJECTIVE MOTOR-ASSESSMENT - THE QUANTITATIVE HOOVERS TEST

      Journal of neurology
    17. DJALDETTI R; MELAMED E
      MANAGEMENT OF RESPONSE FLUCTUATIONS - PRACTICAL GUIDELINES

      Neurology
    18. Ziv, I; Avraham, M; Michaelov, Y; Djaldetti, R; Dressler, R; Zoldan, J; Melamed, E
      Enhanced fatigue during motor performance in patients with Parkinson's disease

      NEUROLOGY
    19. DJALDETTI R; ROSMARIN V; ZIV I; MELAMED E
      THE PHARMACOKINETIC PROFILE OF THE FIRST EVER ORAL DOSE OF LEVODOPA IN DE-NOVO PATIENTS WITH PARKINSONS-DISEASE

      Neurology
    20. ZIV I; SHIRVAN A; BARZILAI A; DJALDETTI R; MELAMED E
      NEURONAL APOPTOSIS TRIGGERED BY DOPAMINE IS ASSOCIATED WITH INDUCTIONOF THE COLLAPSIN SYSTEM

      Neurology
    21. DJALDETTI R; HART J; ALEXANDROVA S; COHEN S; BEILIN B; DJALDETTI M; BESSLER H
      EFFECT OF HIGH-DOSES OF 2-CDA ON SCHWANN-CELLS OF MOUSE PERIPHERAL-NERVE

      Journal of submicroscopic cytology and pathology
    22. DJALDETTI R; ACHIRON A; ZIV I; DJALDETTI M; MELAMED E; FISHMAN P
      IL-3-LA PRODUCTION BY MONONUCLEAR-CELLS OF PATIENTS WITH MULTIPLE-SCLEROSIS - EFFECT OF TREATMENT WITH INTRAVENOUS IMMUNOGLOBULINS (VOL 24,PG 765, 1995)

      Immunological investigations
    23. DJALDETTI R; MELAMED E
      LEVODOPA ETHYLESTER - A NOVEL RESCUE THERAPY FOR RESPONSE FLUCTUATIONS IN PARKINSONS-DISEASE

      Annals of neurology
    24. DJALDETTI R; ATLAS D; MELAMED E
      EFFECT OF SUBCUTANEOUS ADMINISTRATION OF LEVODOPA ETHYL-ESTER, A SOLUBLE PRODRUG OF LEVODOPA, ON DOPAMINE METABOLISM IN RODENT STRIATUM - IMPLICATION FOR TREATMENT OF PARKINSONS-DISEASE

      Clinical neuropharmacology
    25. DJALDETTI R; HART J; ALEXANDROVA S; COHEN S; BEILIN BZ; DJALDETTI M; BESSLER H
      VINCRISTINE-INDUCED ALTERATIONS IN SCHWANN-CELLS OF MOUSE PERIPHERAL-NERVE

      American journal of hematology
    26. ACHIRON A; PINHASHAMIEL O; BARAK Y; DOLL L; OFFEN D; DJALDETTI R; FRANKEL G; SHOHAT B
      DETECTION OF PROVIRAL HUMAN T-CELL LYMPHOTROPHIC VIRUS TYPE-I DNA IN MOUTHWASH SAMPLES OF HAM TSP PATIENTS AND HTLV-I CARRIERS/

      Archives of virology
    27. DJALDETTI R; BARON J; ZIV I; MELAMED E
      GASTRIC-EMPTYING IN PARKINSONS-DISEASE - PATIENTS WITH AND WITHOUT RESPONSE FLUCTUATIONS

      Neurology
    28. DJALDETTI R; ZIV I; ACHIRON A; MELAMED E
      FATIGUE IN MULTIPLE-SCLEROSIS COMPARED WITH CHRONIC FATIGUE SYNDROME - A QUANTITATIVE ASSESSMENT

      Neurology
    29. ZIV I; SHIRVAN A; DJALDETTI R; MICHLIN T; BARZILAI A; MELAMED E
      NEURONAL APOPTOSIS INDUCED BY DOPAMINE IS ASSOCIATED WITH CELL CYCLE-RELATED EVENTS - CLUES FOR NIGRAL DEGENERATION IN PARKINSONS-DISEASE

      Neurology
    30. DJALDETTI R; ZIV I; MELAMED E
      IMPAIRED ABSORPTION OF ORAL LEVODOPA - A MAJOR CAUSE FOR RESPONSE FLUCTUATIONS IN PARKINSONS-DISEASE

      Israel journal of medical sciences
    31. BESSLER H; STRAUSSBERG R; DJALDETTI R; SALMAN H
      THE EFFECT OF ACYCLOVIR ON THE PROLIFERATIVE CAPACITY OF MONONUCLEAR-CELLS FROM PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA

      Israel journal of medical sciences
    32. DJALDETTI R; MELAMED E
      POSTRAUMATIC-DELAYED CEREBELLAR SYNDROME

      Archives of neurology
    33. SHOHAT B; MILLER M; ACHIRON A; DJALDETTI R; SHAKLAI M
      DETECTION OF PROVIRAL HUMAN-T-LYMPHOTROPIC-VIRUS TYPE-I (HTLV-1) DNA AND ANTIBODIES TO HTLV-1 IN SALIVA OF PERSONS AT RISK OF HTLV-1 INFECTION IN ISRAEL

      Journal of acquired immune deficiency syndromes and human retrovirology
    34. DJALDETTI R; KOREN M; ZIV I; ACHIRON A; MELAMED E
      EFFECT OF CISAPRIDE ON RESPONSE FLUCTUATIONS IN PARKINSONS-DISEASE

      Movement disorders
    35. DJALDETTI R; ACHIRON A; ZIV I; DJALDETTI M; MELAMED E; FISHMAN P
      IL-3-LA PRODUCTION BY MONONUCLEAR-CELLS OF PATIENTS WITH MULTIPLE-SCLEROSIS - EFFECT OF TREATMENT WITH INTRAVENOUS IMMUNOGLOBULINS

      Immunological investigations
    36. DJALDETTI R; ACHIRON A; ZIV I; DJALDETTI M
      LYMPHOCYTE ULTRASTRUCTURE IN PATIENTS WITH MULTIPLE-SCLEROSIS

      Biomedicine & pharmacotherapy
    37. DJALDETTI R; ATLAS D; MELAMED E
      LEVODOPA ETHYLESTER - A NOVEL THERAPEUTIC STRATEGY FOR TREATMENT OF RESPONSE FLUCTUATIONS IN PATIENTS WITH PARKINSONS-DISEASE

      Annals of neurology
    38. DABBY R; ABRAHAM M; ZIV I; DJALDETTI R; MELUMED E
      MANUAL MOTOR BLOCKS - CHARACTERIZATION AND QUANTITATIVE ASSESSMENT OFA LESS-RECOGNIZED BUT COMMON FEATURE OF PARKINSONS-DISEASE

      Annals of neurology
    39. DJALDETTI R; ATLAS D; MELAMED E
      SUBCUTANEOUS INJECTIONS OF LEVODOPA ETHYLESTER - A POTENTIAL NOVEL RESCUE THERAPY FOR RESPONSE FLUCTUATIONS IN PATIENTS WITH PARKINSONS-DISEASE

      Neurology
    40. DJALDETTI R; ACHIRON A; ZIV I; MELAMED E
      FIRST EMERGENCE OF DELAYED-ON AND DOSE FAILURE PHENOMENA IN A PATIENTWITH PARKINSONS-DISEASE FOLLOWING VAGOTOMY

      Movement disorders
    41. ZIV I; ACHIRON A; DJALDETTI R; ABRAHAM M; MELAMED E
      CAN NIMODIPINE AFFECT PROGRESSION OF MOTOR-NEURON DISEASE - A DOUBLE-BLIND PILOT-STUDY

      Clinical neuropharmacology
    42. GOLDBERGSTERN H; DJALDETTI R; MELAMED E; GADOTH N
      MACHADO-JOSEPH (AZOREAN)-DISEASE IN A YEMENITE JEWISH FAMILY IN ISRAEL

      Neurology
    43. DJALDETTI R; ACHIRON A; ZIV I; DABBY R; MOSBERG R; MELAMED E
      THE EFFECT OF SINEMET TABLETS VERSUS SUSPENSION OF CRUSHED SINEMET ONDELAYED-ON AND NO-ON FLUCTUATIONS IN PARKINSONS-DISEASE

      Neurology
    44. ACHIRON A; PINHASHAMIEL O; DOLL L; SHOHAT B; CHEN A; DJALDETTI R; ZIV I; MELAMED E; FRANKEL G
      HTLV-1-ASSOCIATED CHRONIC PROGRESSIVE MYELOPATHY IN IRANIAN-BORN JEWS- IMPLICATIONS FOR HORIZONTAL TRANSMISSION BY DETECTION OF PROVIRAL GENOME IN SALIVA

      Neurology
    45. ACHIRON A; PINHASHAMIEL O; DOLL L; DJALDETTI R; CHEN A; ZIV I; AVNI A; FRANKEL G; MELAMED E; SHOHAT B
      SPASTIC PARAPARESIS ASSOCIATED WITH HUMAN T-LYMPHOTROPIC VIRUS TYPE-I- A CLINICAL, SEROLOGICAL, AND GENOMIC STUDY IN IRANIAN-BORN MASHHADIJEWS

      Annals of neurology
    46. ACHIRON A; ZIV I; GILAD R; DJALDETTI R; ZOLDAN Y; SAROVAPINHAS I; MELAMED E
      LONG-TERM INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN RELAPSING-REMITTINGMULTIPLE-SCLEROSIS - 3 YEARS EXPERIENCE

      Annals of neurology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 20:27:28